EffenDys—Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial.

MLA

Simon, Steffen T., et al. “EffenDys—Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial.” Journal of Pain & Symptom Management, vol. 52, no. 5, Nov. 2016, pp. 617–25. EBSCOhost, https://doi.org/10.1016/j.jpainsymman.2016.05.023.

APA

Simon, S. T., Kloke, M., Alt-Epping, B., Gärtner, J., Hellmich, M., Hein, R., Piel, M., Cornely, O. A., Nauck, F., & Voltz, R. (2016). EffenDys—Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial. Journal of Pain & Symptom Management, 52(5), 617–625. https://doi.org/10.1016/j.jpainsymman.2016.05.023

Chicago

Simon, Steffen T., Marianne Kloke, Bernd Alt-Epping, Jan Gärtner, Martin Hellmich, Rebecca Hein, Maren Piel, Oliver A. Cornely, Friedemann Nauck, and Raymond Voltz. 2016. “EffenDys—Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial.” Journal of Pain & Symptom Management 52 (5): 617–25. doi:10.1016/j.jpainsymman.2016.05.023.